Leavitt Partners Blog

Leavitt Partners Future Frame Series: Political Checkpoint
November 21, 2021

While healthcare leaders seek to broaden and deepen their analysis of the implications of recent federal health policy changes, it is challenging to accurately determine where the industry might be headed in 2022 and beyond. On Tuesday, November 9, 2021, Leavitt Partners’ Senior Director of Health Policy Outreach, Jen Colamonico, moderated a Linkedin Live Political Checkpoint broadcast featuring Liz Wroe, […]

Read More >
Leavitt Partners Future Frame Series – Health Disparities: A Time For Action
October 29, 2021

Many healthcare industry leaders understand that health disparities are a problem, and likely have made public-facing commitments to underscore those concerns. But it is hard to know where to begin to make systemic changes that will reduce disparities. On Thursday, October 14, 2021, Leavitt Partners’ CEO, Andrew Croshaw, moderated a LinkedIn Live broadcast featuring Maddy Shea, Ph.D., […]

Read More >
Leavitt Partners Future Frame Series: Vaccine Credentialing – How The Private Sector Is Getting The Economy Moving Again
September 22, 2021

Credible proof of vaccination status is critical for businesses to stay open as the COVID pandemic wears on, but paper vaccine cards are less reliable given the propensity for fraud. On September 16, 2021, Leavitt Partners’ CEO, Andrew Croshaw, moderated a LinkedIn Live broadcast featuring Ryan Howells, Principal at Leavitt Partners; JP Pollack, co-founder and Chief Architect […]

Read More >
The Delta Variant: What We Know, What We Don’t Know, And What Employers Should Do About It
August 4, 2021

Employers are in a bind. In the U.S., the COVID-19 case counts and hospitalizations were on a steady decline during June. Businesses were tentatively welcoming employees back to the office—unmasked—and the market environment was stabilizing. The Delta variant, however, is challenging that sense of normalcy. With the cluster of cases spread among vaccinated party-goers in […]

Read More >
Leavitt Partners Future Frame Series: The Value Imperative For The Pharmaceutical Industry
August 2, 2021

Written By: Leavitt Partners August 02, 2021 On July 16, Leavitt Partners’ CEO Andrew Croshaw moderated a discussion between Jeremy Bahr, Principal at Leavitt Partners, and Prem Kumar, Senior Advisor to Leavitt Partners, focused on trends in U.S. healthcare that affect the pharmaceutical industry, and how pharmaceutical companies may need to evolve to succeed in a value-driven healthcare environment.  Read more […]

Read More >
Leavitt Partners Future Frame Series: The Value Imperative For The Pharmaceutical Industry
August 2, 2021

On July 16, Leavitt Partners’ CEO Andrew Croshaw moderated a discussion between Jeremy Bahr, Principal at Leavitt Partners, and Prem Kumar, Senior Advisor to Leavitt Partners, focused on trends in U.S. healthcare that affect the pharmaceutical industry, and how pharmaceutical companies may need to evolve to succeed in a value-driven healthcare environment.  Andrew opened the discussion with a reflection that this conversation is happening […]

Read More >
Leavitt Partners Future Frame Series – Political Checkpoint: An Inflection Point
July 2, 2021

On June 24, Leavitt Partners hosted a LinkedIn Live broadcast titled “Political Checkpoint: An Inflection Point” featuring Josh Trent, Jennifer Colamonico, and moderated by Andrew Croshaw. Josh and Jen discussed the political inflection point we are in as the country emerges from the pandemic and the Administration and Congress work on health policy priorities ahead of the 2022 midterms. The speakers also shared insights into how health policy developments—including those that […]

Read More >
Leavitt Partners Future Frame Series: Strategic Approaches To Reducing Health Disparities At The State Level
June 17, 2021

Leavitt Partners’ CEO Andrew Croshaw recently moderated a discussion between Patricia Doxey and Dulce Diez, the Director of the Office of Health Disparities (OHD) for the Utah Department of Health, highlighting key opportunities to reduce health disparities. The panel discussed the market flaws revealed by COVID-19 and Utah OHD’s framework for addressing health inequities, which […]

Read More >